The early gut microbiome could protect against severe retinopathy of prematurity

Area of Science:

• Microbiology
• Neonatology
• Gastroenterology

Background:

• Retinopathy of prematurity (ROP) is a significant cause of visual impairment in preterm infants.
• The gut microbiome's role in neonatal health and disease is increasingly recognized.
• Understanding factors influencing ROP pathogenesis is crucial for preventative strategies.

Purpose of the Study:

• To investigate the association between the gut microbiome composition and the development of type 1 retinopathy of prematurity (ROP).
• To compare the gut microbiota profiles of infants with and without ROP.

Main Methods:

• Comparative analysis of gut microbiota composition in two groups of preterm infants (with and without type 1 ROP) at 28 weeks' postmenstrual age.
• Utilized 16S rRNA sequencing or similar metagenomic techniques to characterize microbial communities.
• Analyzed metabolic pathways associated with gut microbiota profiles.

Main Results:

• Infants with type 1 ROP exhibited a significant enrichment of Enterobacteriaceae.
• Infants without ROP showed enrichment in several metabolic pathways, including amino acid metabolism.
• A distinct gut microbiome profile was observed between ROP and non-ROP groups.

Conclusions:

• Early gut microbiome profiles may be associated with the pathogenesis of retinopathy of prematurity.
• The absence of Enterobacteriaceae overabundance and the presence of amino acid biosynthesis pathways might offer protection against severe ROP.
• Further research into microbiome-targeted interventions for ROP prevention is warranted.